Solventum Corp.

NYSE:SOLV USA Medical Instruments & Supplies
Market Cap
$11.91 Billion
Market Cap Rank
#1672 Global
#1242 in USA
Share Price
$68.67
Change (1 day)
+2.28%
52-Week Range
$63.01 - $86.14
All Time High
$86.14
About

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advance… Read more

Solventum Corp. (SOLV) - Total Assets

Latest total assets as of September 2025: $13.97 Billion USD

Based on the latest financial reports, Solventum Corp. (SOLV) holds total assets worth $13.97 Billion USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Solventum Corp. - Total Assets Trend (2021–2024)

This chart illustrates how Solventum Corp.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Solventum Corp. - Asset Composition Analysis

Current Asset Composition (December 2024)

Solventum Corp.'s total assets of $13.97 Billion consist of 22.5% current assets and 77.5% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 5.3%
Accounts Receivable $1.23 Billion 8.5%
Inventory $965.00 Million 6.7%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $2.54 Billion 17.6%
Goodwill $6.38 Billion 44.1%

Asset Composition Trend (2021–2024)

This chart illustrates how Solventum Corp.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Solventum Corp.'s current assets represent 22.5% of total assets in 2024, an increase from 15.6% in 2021.
  • Cash Position: Cash and equivalents constituted 5.3% of total assets in 2024, up from 0.7% in 2021.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 61.0% of total assets, a decrease from 73.0% in 2021.
  • Asset Diversification: The largest asset category is goodwill at 44.1% of total assets.

Solventum Corp. Competitors by Total Assets

Key competitors of Solventum Corp. based on total assets are shown below.

Company Country Total Assets
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
China CN¥3.82 Billion
Blue Sail Medical Co Ltd
SHE:002382
China CN¥16.46 Billion
Andon Health Co Ltd
SHE:002432
China CN¥28.98 Billion
Allmed Medical Products Co Ltd Class A
SHE:002950
China CN¥5.35 Billion
Inix Technologies Holdings Bhd
KLSE:0094
Malaysia RM72.53 Million
Focus Point Holdings Bhd
KLSE:0157
Malaysia RM328.19 Million
Careplus Group Bhd
KLSE:0163
Malaysia RM286.61 Million
LKL International Bhd
KLSE:0182
Malaysia RM173.46 Million

Solventum Corp. - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.57 - 0.60

Moderate asset utilization - Solventum Corp. generates 0.57x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: 3.31% - 10.37%

Moderate ROA - For every $100 in assets, Solventum Corp. generates $ 3.31 in net profit.

Solventum Corp. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.50 1.15 1.70
Quick Ratio 1.14 0.83 1.04
Cash Ratio 0.00 0.00 0.00
Working Capital $1.47 Billion $ 450.00 Million $ 920.00 Million

Solventum Corp. - Advanced Valuation Insights

This section examines the relationship between Solventum Corp.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.72
Latest Market Cap to Assets Ratio 0.70
Asset Growth Rate (YoY) 3.7%
Total Assets $14.46 Billion
Market Capitalization $10.12 Billion USD

Valuation Analysis

Below Book Valuation: The market values Solventum Corp.'s assets below their book value (0.70 x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Solventum Corp.'s assets grew by 3.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Solventum Corp. (2021–2024)

The table below shows the annual total assets of Solventum Corp. from 2021 to 2024.

Year Total Assets Change
2024-12-31 $14.46 Billion +3.69%
2023-12-31 $13.94 Billion +2.57%
2022-12-31 $13.59 Billion -3.42%
2021-12-31 $14.07 Billion --